¿Es posible usar probióticos para prevenir o tratar la obesidad en perros?
Open Access
- 2 January 2025
- journal article
- Published by Abanico
- Vol. 1, e2025-4
Abstract
La obesidad canina es un trastorno metabólico complejo y multifactorial que ha aumentado de forma alarmante en todo el mundo, lo que afecta tanto la salud animal como la salud pública. Más allá de la sobrealimentación y la falta de ejercicio, las investigaciones actuales destacan a la microbiota intestinal como un regulador clave del equilibrio metabólico. Las alteraciones en su composición (como el incremento en la relación Firmicutes/Bacteroidetes, y la pérdida de diversidad microbiana) perturban la absorción de nutrientes, el metabolismo de lípidos y la regulación inmunológica, esto genera un entorno proinflamatorio que favorece la acumulación de grasa. Los probióticos, definidos como microorganismos vivos que promueven la salud al administrarse en cantidades adecuadas, muestran potencial para restaurar el equilibrio intestinal y mejorar el metabolismo del hospedero. Su mecanismo de acción implica reforzar la barrera intestinal, modular la respuesta inmunológica y producir ácidos grasos de cadena corta que regulan el uso energético. Sin embargo, la mayoría de los probióticos comerciales para perros derivan de cepas humanas, no diseñadas específicamente para trastornos metabólicos. Evidencias recientes sugieren que cepas de Lactobacillus, Bifidobacterium y Enterococcus de origen canino pueden reducir la adiposidad y mejorar la salud metabólica. El desarrollo de probióticos específicos para perros podría integrarse a estrategias dietéticas y conductuales sostenibles, dentro del marco “Una Salud” que vincula el bienestar animal y humano. https://doi.org/10.21929/abanicomicrobiano/2025.4 2025-04 https://www.youtube.com/watch?v=OfjG63UUW2s Canine obesity is a complex metabolic disorder that has become increasingly common worldwide, affecting not only animal health but also public health and welfare. Beyond excessive feeding and limited exercise, current research highlights the gut microbiota as a central regulator of metabolic balance. Alterations in its composition (such as an increased Firmicutes/Bacteroidetes ratio, and loss of microbial diversity) disrupt nutrient absorption, lipid metabolism, and immune regulation, creating a pro-inflammatory environment that favors fat accumulation. Probiotics, defined as live microorganisms that promote health when administered in sufficient quantities, have shown potential to restore intestinal balance and improve host metabolism. They act by strengthening the intestinal barrier, modulating immunity, and producing short-chain fatty acids that regulate energy use. However, most commercial probiotics for dogs are adapted from human strains and not specifically developed for metabolic disorders. Emerging evidence suggests that canine-derived strains of Lactobacillus, Bifidobacterium, and Enterococcus may help reduce adiposity and improve metabolic health. Designing next-generation, species-specific probiotics could complement dietary and behavioral interventions, offering a sustainable, microbiota-based strategy to prevent and manage obesity in dogs within the broader “One Health” perspective linking animal and human well-being. https://doi.org/10.21929/abanicomicrobiano/2025.4 2025-04 https://www.youtube.com/watch?v=OfjG63UUW2sKeywords
This publication has 15 references indexed in Scilit:
- Behavior Changes Associated with Metabolic Disease of Dogs and CatsVeterinary Clinics of North America: Small Animal Practice, 2023
- Obese dogs exhibit different fecal microbiome and specific microbial networks compared with normal weight dogsScientific Reports, 2023
- Gut Microbiome and Its Impact on Obesity and Obesity-Related DisordersCurrent Gastroenterology Reports, 2022
- Value of Probiotics in Canine and Feline GastroenterologyVeterinary Clinics of North America: Small Animal Practice, 2021
- A Comparative Study of Serum Biochemistry, Metabolome and Microbiome Parameters of Clinically Healthy, Normal Weight, Overweight, and Obese Companion DogsTopics in Companion Animal Medicine, 2018
- The fecal microbiome and metabolome differs between dogs fed Bones and Raw Food (BARF) diets and dogs fed commercial dietsPLOS ONE, 2018
- A canine-specific probiotic product in treating acute or intermittent diarrhea in dogs: A double-blind placebo-controlled efficacy studyVeterinary Microbiology, 2016
- Microbiota and probiotics in canine and feline welfareAnaerobe, 2015
- The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probioticNature Reviews Gastroenterology & Hepatology, 2014
- Pyrosequencing the Canine Faecal Microbiota: Breadth and Depth of BiodiversityPLOS ONE, 2013